Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

C. Twelves; W. Scheithauer; J. Mckendrick; J.-F. Seitz; Guy Van Hazel; A. Wong; E. Díaz-Rubio; F. Gilberg; J. Cassidy

doi:10.1093/annonc/mdr366

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

C. Twelves, W. Scheithauer, J. Mckendrick, J.-F. Seitz, Guy Van Hazel, A. Wong, E. Díaz-Rubio, F. Gilberg, J. Cassidy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1190-1197
Journal	Annals of Oncology
Volume	23
DOIs	https://doi.org/10.1093/annonc/mdr366
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdr366

Cite this

Twelves, C., Scheithauer, W., Mckendrick, J., Seitz, J.-F., Van Hazel, G., Wong, A., Díaz-Rubio, E., Gilberg, F., & Cassidy, J. (2012). Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Annals of Oncology, 23, 1190-1197. https://doi.org/10.1093/annonc/mdr366

@article{106a8e98d48a46138918d04f214b93a4,

title = "Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy",

author = "C. Twelves and W. Scheithauer and J. Mckendrick and J.-F. Seitz and {Van Hazel}, Guy and A. Wong and E. D{\'i}az-Rubio and F. Gilberg and J. Cassidy",

year = "2012",

doi = "10.1093/annonc/mdr366",

language = "English",

volume = "23",

pages = "1190--1197",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Twelves, C, Scheithauer, W, Mckendrick, J, Seitz, J-F, Van Hazel, G, Wong, A, Díaz-Rubio, E, Gilberg, F & Cassidy, J 2012, 'Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy', Annals of Oncology, vol. 23, pp. 1190-1197. https://doi.org/10.1093/annonc/mdr366

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. / Twelves, C.; Scheithauer, W.; Mckendrick, J. et al.
In: Annals of Oncology, Vol. 23, 2012, p. 1190-1197.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: Final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

AU - Twelves, C.

AU - Scheithauer, W.

AU - Mckendrick, J.

AU - Seitz, J.-F.

AU - Van Hazel, Guy

AU - Wong, A.

AU - Díaz-Rubio, E.

AU - Gilberg, F.

AU - Cassidy, J.

PY - 2012

Y1 - 2012

U2 - 10.1093/annonc/mdr366

DO - 10.1093/annonc/mdr366

M3 - Article

SN - 0923-7534

VL - 23

SP - 1190

EP - 1197

JO - Annals of Oncology

JF - Annals of Oncology

ER -